about
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offe...
Read More
92.00
5.40
(6.24%)
1.3M
XNAS Volume
XNAS 14 Aug, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Celcuity Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..